Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Oligodendrocyte Fate after Spinal Cord Injury

Oligodendrocyte Fate after Spinal Cord Injury

Neurotherapeutics, 2011 · DOI: 10.1007/s13311-011-0033-5 · Published: April 1, 2011

Spinal Cord InjuryNeurology

Simple Explanation

After a spinal cord injury, oligodendrocytes, which are essential for insulating nerve fibers, are highly vulnerable and die off, leading to demyelination. This loss impairs the function and survival of axons, the long threads that carry nerve signals. In response to this damage, the body attempts to repair itself by generating new oligodendrocyte progenitor cells, especially around the injury site. These cells can mature into oligodendrocytes and begin to remyelinate damaged axons, typically starting about two weeks after the injury. The review analyzes mechanisms of oligodendrocyte loss and replacement, and myelination after SCI, highlighting areas for potential therapeutic intervention. It further discusses studies focused on protecting existing oligodendrocytes and replacing lost ones through growth factors and cell transplantation.

Study Duration
Not specified
Participants
Rodent models of SCI, nonhuman primates, and human patients
Evidence Level
Review

Key Findings

  • 1
    Oligodendrocytes are particularly susceptible to the toxic environment created by spinal cord injury, leading to their death through both necrosis and apoptosis.
  • 2
    The body initiates a proliferative response of oligodendrocyte progenitor cells, particularly at the lesion borders, which can differentiate into myelinating oligodendrocytes to remyelinate axons.
  • 3
    Factors involved in oligodendrocyte specification, migration, and differentiation during development are reactivated after SCI, suggesting an attempt to rebuild myelin in a way that mimics the developmental process.

Research Summary

Oligodendrocytes (OLs) are particularly susceptible to the toxicity of the acute lesion environment after spinal cord injury (SCI). They undergo both necrosis and apoptosis acutely, with apoptosis continuing at chronic time points. Loss of OLs causes demyelination and impairs axon function and survival. In parallel, a rapid and protracted OL progenitor cell proliferative response occurs, especially at the lesion borders. For therapies targeting oligogenesis to be successful, endogenous responses and the effects of the acute and chronic lesion environment on OL lineage cells must be understood in detail, and in relation, the optimal therapeutic window for such strategies must also be determined.

Practical Implications

Therapeutic Targets

Identifying mechanisms of OL loss and replacement provides targets for therapeutic interventions after SCI.

Growth Factor Use

Growth factors can boost the endogenous progenitor response and facilitate survival and OL fate in conjunction with progenitor transplantation.

Stem Cell Therapies

Embryonic stem cell-derived cells and adult neural progenitor cells have shown considerable progress in OL protection and replacement.

Study Limitations

  • 1
    The endogenous oligogenic response is insufficient against OL loss and demyelination.
  • 2
    Optimal therapeutic window for strategies targeting oligogenesis must be determined.
  • 3
    Effects of the acute and chronic lesion environment on OL lineage cells must be understood in detail.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury